4

OWNERSHIP DOCUMENT

Company: ADIAL PHARMACEUTICALS, INC.
Filed: March 5, 2020
Period of Report: March 3, 2020
Accession Number: 0001213900-20-005545

View Document ↗ View on SEC.gov ↗